Key result
Increased visceral adipose tissue area (>175 cm2) was a robust independent risk factor for in-hospital mortality in COVID-19 patients (p<0.0001).
Why the study?
Obesity is a major risk factor for COVID-19 deterioration and mortality, but the specific role of visceral adipose tissue burden compared with other obesity markers required elucidation.
Does high visceral adipose tissue burden increase mortality and inflammatory responses in COVID-19 patients and SARS-CoV-2 infected mice?
Observational (n=250)
No
Does high visceral adipose tissue burden increase mortality and inflammatory responses in COVID-19 patients and SARS-CoV-2 infected mice?
p-value: p=<0.0001
Visceral adipose tissue accumulation is a significant risk factor for COVID-19 mortality, driven by macrophage-mediated cytokine storms, suggesting these patients may benefit from early anti-cytokine therapy.
May aid COVID-19 risk stratification; leaves open whether visceral fat-targeted interventions alter outcomes.
Obesity is one of the most significant risk factors for the deterioration and mortality associated with COVID-19 [1]. A certain proportion of COVID-19 patients experience marked elevations of inflammatory mediators, termed “cytokine storm”, resulting in the deterioration of the respiratory condition [2,3]. In the present study, we elucidate that the high visceral adipose tissue (VAT) burden was more closely related to accelerated inflammatory responses and the mortality of Japanese COVID-19 patients than other obesity-associated markers, including body mass index (BMI). To explore a novel stratification of COVID-19 patients, we infected mouse-adapted SARS-CoV-2 in several obese mice, revealing that VAT-dominant ob/ob mice and diet-induced obesity obese mice died after infection with low-titer mouse-adapted SARS-CoV-2 virus due to the subsequent cytokine storm, whereas none of the subcutaneous adipose tissue (SAT) dominant db/db mice or control lean wild-type mice died. SARS-CoV-2 genome and proteins were more abundant in the lungs of ob/ob mice, engulfed in macrophages, resulting in increased production of inflammatory cytokine represented by IL-6. As well as the anti-IL-6 treatment, the prevention of obesity by leptin administration improved the survival of SARS-CoV-2 infected ob/ob mice by reducing the viral protein burden and excessive immune responses.
No takes yet. Share an insight, caveat, or question.
Hosoya et al. (2022) conducted an observational in COVID-19 (n=250). High visceral adipose tissue (VAT) burden (>175 cm2) vs. Low visceral adipose tissue burden was evaluated on In-hospital mortality (p=<0.0001). Increased visceral adipose tissue area (>175 cm2) was a robust independent risk factor for in-hospital mortality in COVID-19 patients (p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: